HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Marc de Perrot Masaki Anraku Thomas K. Waddell Andrew F. Pierre Gail Darling Shaf Keshavjee Michael R. Johnston Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Perrot, M. Articles by Johnston, M. R. Search for Related Content PubMed PubMed Citation Articles by de Perrot, M. Articles by Johnston, M. R. Related Collections Pleura

---

Original Articles: General Thoracic

Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma

^a Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
^b Department of Anesthesia, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Accepted for publication November 26, 2007.

^_* Address correspondence to Dr de Perrot, Division of Thoracic Surgery, Toronto General Hospital, 9N-961, 200 Elizabeth St, Toronto, Ontario, M5G 2C4, Canada (Email: marc.deperrot{at}uhn.on.ca).

Background: Factors associated with increased risk of major complications after extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma are not well characterized; in particular, the risks of induction chemotherapy and red blood cell (RBC) transfusion have not been well defined.

Methods: We reviewed our experience with 62 consecutive EPP (28 right sided) performed in our institution for malignant pleural mesothelioma between January 1993 and May 2007. A total of 44 patients underwent induction chemotherapy with cisplatin-based therapy.

Results: The majority of patients (88%) received RBC transfusions (median, 4 units; range, 0 to 18 units). Patients undergoing induction chemotherapy had lower preoperative hemoglobin (122 ± 16 g/L versus 134 ± 15 g/L in the remaining patients, p = 0.02) and received more RBC transfusions (5.1 ± 3.5 units versus 2.1 ± 2.3 units in the remaining patients, p = 0.007). Twenty-two patients (35%) experienced major postoperative complications and 4 of them died (6.5%). Patients experiencing major complications were older (60 ± 8 years versus 56 ± 12 years, respectively; p = 0.2) and received more RBC transfusions (5.8 ± 4.3 units versus 3.7 ± 2.7 units, respectively; p = 0.02). Major complications occurred more frequently after right-sided EPP than after left-sided EPP (54% versus 21%, p = 0.007). Induction chemotherapy had no impact on the risk of major complications (p = 0.5). Transfusion of more than 4 units of RBC (p = 0.01) and right-sided EPP (p = 0.01) were associated with increased risk of major complications after EPP in multivariate analysis.

Conclusions: Right EPP and more than 4 units of RBC transfusion are associated with increased risk of major complications. Although patients undergoing induction chemotherapy received more RBC transfusions, induction chemotherapy did not directly impact the risk of major complications.

This article has been cited by other articles:

				D. S. Trousse, J.-P. Avaro, X. B. D'Journo, C. Doddoli, P. Astoul, R. Giudicelli, P. A. Fuentes, and P. A. Thomas Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 759 - 763. [Abstract] [Full Text] [PDF]

				T. D. Yan, M. Boyer, M. M. Tin, D. Wong, C. Kennedy, J. McLean, P. G. Bannon, and B. C. McCaughan Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 619 - 624. [Abstract] [Full Text] [PDF]